Sebastian River Holdings, Inc. Secures Development, Manufacturing Partner for Synerlife Subsidiary

Sebastian River Holdings, Inc. Secures Development, Manufacturing Partner for Synerlife Subsidiary

TORRANCE, Calif.--(BUSINESS WIRE)-- Sebastian River Holdings, Inc.(USOTC: SBRH) is pleased to announce that it has signed an agreement with The Medicine Man's Corner of Albany, Georgia ( its founder, Dr. Charlie Rouse, to develop proprietary health supplement products for Sebastian's wholly-owned subsidiary, Synerlife. As well, once formulated, the products will be manufactured for Synerlife's plan of action to market and sell the products B2B nationwide with domestic sales partners as well as via online portals internationally.

"We are thrilled to have signed with Dr. Rouse," states Sebastian Director, Peter Matousek. "His expertise in the field is both extensive and impressive and we are confident that partnering with him will effect a successful launch of products for the Synerlife brand."

Dr. Charlie Rouse is a husband, father, pastor, author, lecturer, product formulator, radio and television personality. He is a Doctor of Natural Medicine and a pharmacist and is an expert on the biochemical and pharmacological features of both natural supplements and pharmaceutical drugs. Dr. Rouse has steered thousands of people toward richer, healthier lives.

The agreement allows for Synerlife to give Medicine Man instruction as to specific ingredients to be added to the respective formulations of Medicine Man in order to make each separate product differ from any similar item that Medicine Man currently sells. As well, per the agreement, Synerlife shall have the exclusive rights to market the formulations specially developed according to its direction and shall be given rights as the exclusive distributor for said special formulations so long as they differ from the formulations sold by The Medicine Man's store and/or website or other distributors.

Sebastian management will be looking to develop and sell highly useful supplements which are top quality with high margins including male enhancement formulas, cancer prevention formulas and REM sleep aids to name a few. The Company's flagship will be announced shortly and will be aligned with a marketing campaign for sales.

More updates to come on this as well as the Company's partial ownership in the Master Lease of Cranberry Township in Western Pennsylvania in the coming days.

Forward-Looking Safe Harbor
This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and/or OTC Markets Disclosure & News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Sebastian River Holdings, Inc.
Peter Matousek, 424-258-0167

Sebastian River Holdings, Inc.
Peter Matousek, 424-258-0167

KEYWORDS: United States North America California Georgia


The article Sebastian River Holdings, Inc. Secures Development, Manufacturing Partner for Synerlife Subsidiary originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.